Physician profile
Jonathan Perwien
NPI 1720196322
$11,606.74
in general payments reported to CMS, 2019-2025
44 companies · $1,799 in 2025
The $1,799 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,084 · 2020: $1,465 · 2021: $1,273 · 2022: $1,580 · 2023: $1,586 · 2024: $1,819 · 2025: $1,799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,204.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,783.21 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,225.37 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $966.14 | 2019-2025 | Repatha, Otezla, Otezla |
| Janssen Pharmaceuticals, INC | $803.55 | 2019-2024 | Xarelto, Spravato |
| Astrazeneca Pharmaceuticals LP | $793.26 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $597.92 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $549.96 | 2019-2025 | Jardiance, Tradjenta |
| Bayer Healthcare Pharmaceuticals INC. | $477.29 | 2022-2025 | |
| Abbvie INC. | $467.73 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $443.85 | 2019-2025 | |
| Amarin Pharma, INC. | $409.91 | 2019-2022 | |
| Exact Sciences Corporation | $379.58 | 2023-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $351.50 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astellas Pharma US INC | $331.89 | 2019-2025 | Veozah |
| Merck Sharp & Dohme LLC | $247.88 | 2019-2025 | Belsomra, Gardasil 9, Capvaxive |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Perwien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.